Bioavailability of interleukin-2 after reconstitution with albumin
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 1992-07, Vol.340 (8813), p.241-241 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 241 |
|---|---|
| container_issue | 8813 |
| container_start_page | 241 |
| container_title | The Lancet (British edition) |
| container_volume | 340 |
| creator | Lamers, C.H.J. Stoter, G. Goey, S.H. Oosterom, R. Bolhuis, R.L.H. |
| description | |
| doi_str_mv | 10.1016/0140-6736(92)90507-Y |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_73074660</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>014067369290507Y</els_id><sourcerecordid>73074660</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-3505224400ec6fdaf67e046232a1fc2a1095d2994599e1d5f0186973580d7cc33</originalsourceid><addsrcrecordid>eNqNkU1rVDEUhoNY6lj9Bwp3IWIpV0--JxuhHapVCm4U7CpkchOM3knaJLel_74Z7zDupJuEcJ73cM4ThF5heI8Biw-AGfRCUvFOkWMFHGR_9QQtMJOs50z-fIoWe-QZel7KbwBgAvghOsSUUyxggc7OQjK3JoxmHcZQ77vkuxCry6Ob_oTYk8749uqysymWGupUQ4rdXai_OjOup02IL9CBN2NxL3f3Efrx6fz76qK__Pb5y-r0srd0KWpPOXBCGANwVvjBeCFdG4dQYrC37QDFB6IU40o5PHAPeCmUpHwJg7SW0iP0du57ndPN5ErVm1CsG0cTXZqKlhQkEwIayGbQ5lRKdl5f57Ax-V5j0Ft1eutFb71oRfRfdfqqxV7v-k_rjRv-hWZXrf5mVzfFmtFnE20oe4xzUKBUw5YzdufWyRcbXLRuT51ipcjXc9m2AqBkFarZCl2lKdYWPXl8tNEfZ9o16bfBZb1LDKH9VtVDCv9f-AG8vaqE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73074660</pqid></control><display><type>article</type><title>Bioavailability of interleukin-2 after reconstitution with albumin</title><source>Web of Science - Science Citation Index Expanded - 1992<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>MEDLINE</source><source>Business Source Complete</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Lamers, C.H.J. ; Stoter, G. ; Goey, S.H. ; Oosterom, R. ; Bolhuis, R.L.H.</creator><creatorcontrib>Lamers, C.H.J. ; Stoter, G. ; Goey, S.H. ; Oosterom, R. ; Bolhuis, R.L.H.</creatorcontrib><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/0140-6736(92)90507-Y</identifier><identifier>PMID: 1353160</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>LONDON: Elsevier Ltd</publisher><subject>Biological and medical sciences ; Biological Availability ; General & Internal Medicine ; Humans ; Interleukin-2 - pharmacokinetics ; Kidney Neoplasms - drug therapy ; Life Sciences & Biomedicine ; Medical sciences ; Medicine, General & Internal ; Pharmacology. Drug treatments ; Science & Technology ; Serum Albumin - administration & dosage</subject><ispartof>The Lancet (British edition), 1992-07, Vol.340 (8813), p.241-241</ispartof><rights>1992</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>5</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wosA1992JE75800032</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c386t-3505224400ec6fdaf67e046232a1fc2a1095d2994599e1d5f0186973580d7cc33</citedby><cites>FETCH-LOGICAL-c386t-3505224400ec6fdaf67e046232a1fc2a1095d2994599e1d5f0186973580d7cc33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0140-6736(92)90507-Y$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,782,786,3552,27199,27931,27932,46002,64394</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5509099$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1353160$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lamers, C.H.J.</creatorcontrib><creatorcontrib>Stoter, G.</creatorcontrib><creatorcontrib>Goey, S.H.</creatorcontrib><creatorcontrib>Oosterom, R.</creatorcontrib><creatorcontrib>Bolhuis, R.L.H.</creatorcontrib><title>Bioavailability of interleukin-2 after reconstitution with albumin</title><title>The Lancet (British edition)</title><addtitle>LANCET</addtitle><addtitle>Lancet</addtitle><subject>Biological and medical sciences</subject><subject>Biological Availability</subject><subject>General & Internal Medicine</subject><subject>Humans</subject><subject>Interleukin-2 - pharmacokinetics</subject><subject>Kidney Neoplasms - drug therapy</subject><subject>Life Sciences & Biomedicine</subject><subject>Medical sciences</subject><subject>Medicine, General & Internal</subject><subject>Pharmacology. Drug treatments</subject><subject>Science & Technology</subject><subject>Serum Albumin - administration & dosage</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EZCTM</sourceid><sourceid>EIF</sourceid><recordid>eNqNkU1rVDEUhoNY6lj9Bwp3IWIpV0--JxuhHapVCm4U7CpkchOM3knaJLel_74Z7zDupJuEcJ73cM4ThF5heI8Biw-AGfRCUvFOkWMFHGR_9QQtMJOs50z-fIoWe-QZel7KbwBgAvghOsSUUyxggc7OQjK3JoxmHcZQ77vkuxCry6Ob_oTYk8749uqysymWGupUQ4rdXai_OjOup02IL9CBN2NxL3f3Efrx6fz76qK__Pb5y-r0srd0KWpPOXBCGANwVvjBeCFdG4dQYrC37QDFB6IU40o5PHAPeCmUpHwJg7SW0iP0du57ndPN5ErVm1CsG0cTXZqKlhQkEwIayGbQ5lRKdl5f57Ax-V5j0Ft1eutFb71oRfRfdfqqxV7v-k_rjRv-hWZXrf5mVzfFmtFnE20oe4xzUKBUw5YzdufWyRcbXLRuT51ipcjXc9m2AqBkFarZCl2lKdYWPXl8tNEfZ9o16bfBZb1LDKH9VtVDCv9f-AG8vaqE</recordid><startdate>19920725</startdate><enddate>19920725</enddate><creator>Lamers, C.H.J.</creator><creator>Stoter, G.</creator><creator>Goey, S.H.</creator><creator>Oosterom, R.</creator><creator>Bolhuis, R.L.H.</creator><general>Elsevier Ltd</general><general>LANCET LTD</general><general>Lancet</general><scope>BLEPL</scope><scope>DTL</scope><scope>EZCTM</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19920725</creationdate><title>Bioavailability of interleukin-2 after reconstitution with albumin</title><author>Lamers, C.H.J. ; Stoter, G. ; Goey, S.H. ; Oosterom, R. ; Bolhuis, R.L.H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-3505224400ec6fdaf67e046232a1fc2a1095d2994599e1d5f0186973580d7cc33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Biological and medical sciences</topic><topic>Biological Availability</topic><topic>General & Internal Medicine</topic><topic>Humans</topic><topic>Interleukin-2 - pharmacokinetics</topic><topic>Kidney Neoplasms - drug therapy</topic><topic>Life Sciences & Biomedicine</topic><topic>Medical sciences</topic><topic>Medicine, General & Internal</topic><topic>Pharmacology. Drug treatments</topic><topic>Science & Technology</topic><topic>Serum Albumin - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lamers, C.H.J.</creatorcontrib><creatorcontrib>Stoter, G.</creatorcontrib><creatorcontrib>Goey, S.H.</creatorcontrib><creatorcontrib>Oosterom, R.</creatorcontrib><creatorcontrib>Bolhuis, R.L.H.</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 1992</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lamers, C.H.J.</au><au>Stoter, G.</au><au>Goey, S.H.</au><au>Oosterom, R.</au><au>Bolhuis, R.L.H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bioavailability of interleukin-2 after reconstitution with albumin</atitle><jtitle>The Lancet (British edition)</jtitle><stitle>LANCET</stitle><addtitle>Lancet</addtitle><date>1992-07-25</date><risdate>1992</risdate><volume>340</volume><issue>8813</issue><spage>241</spage><epage>241</epage><pages>241-241</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><cop>LONDON</cop><pub>Elsevier Ltd</pub><pmid>1353160</pmid><doi>10.1016/0140-6736(92)90507-Y</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 1992-07, Vol.340 (8813), p.241-241 |
| issn | 0140-6736 1474-547X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73074660 |
| source | Web of Science - Science Citation Index Expanded - 1992<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; MEDLINE; Business Source Complete; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
| subjects | Biological and medical sciences Biological Availability General & Internal Medicine Humans Interleukin-2 - pharmacokinetics Kidney Neoplasms - drug therapy Life Sciences & Biomedicine Medical sciences Medicine, General & Internal Pharmacology. Drug treatments Science & Technology Serum Albumin - administration & dosage |
| title | Bioavailability of interleukin-2 after reconstitution with albumin |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T08%3A41%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bioavailability%20of%20interleukin-2%20after%20reconstitution%20with%20albumin&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Lamers,%20C.H.J.&rft.date=1992-07-25&rft.volume=340&rft.issue=8813&rft.spage=241&rft.epage=241&rft.pages=241-241&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/0140-6736(92)90507-Y&rft_dat=%3Cproquest_pubme%3E73074660%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73074660&rft_id=info:pmid/1353160&rft_els_id=014067369290507Y&rfr_iscdi=true |